Analysts expect Ambev to report Q3 2026 revenue of 22.39 billion BRL and EPS of 0.26 BRL, with the stock currently trading at 16.68 BRL, slightly above the average analyst price target of 16.30 BRL. Investors are primarily focused on the "Brazil Beer cash cost of goods sold per hectoliter" (CPHL) as a key metric for margin health, following the company's full-year 2026 growth guidance of 4.5% to 7.5%.
The market is looking for evidence that premium brands like Corona and Spaten can continue driving revenue per hectoliter to offset inflationary pressures in other South American markets. While margin expansion is anticipated due to more favorable commodity hedges, persistent economic volatility in Argentina remains a significant headwind for the consolidated bottom line.